Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 33 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 12, 2026 22:13 UTC |
Meek David D.Director
|
SaleOrdinary Shares | 1,993 | $27.06 | $53,930.58 |
DisclosureSEC source: 0000904454-26-000352 · edgar.xml · nonDerivative · entry 2 Meek David D. · CIK 0001555337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,747 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:08 UTC |
Balachandran MadhavanDirector
|
SaleOrdinary Shares | 1,993 | $27.06 | $53,930.58 |
DisclosureSEC source: 0000904454-26-000337 · edgar.xml · nonDerivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,254 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 22:04 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 2,726 | $27.06 | $73,765.56 |
DisclosureSEC source: 0000904454-26-000350 · edgar.xml · nonDerivative · entry 6 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,259 F6 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F6 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:55 UTC |
O'Keefe KylieChief Customer & Strat Officer
|
SaleOrdinary Shares | 15,936 | $27.06 | $431,228.16 |
DisclosureSEC source: 0000904454-26-000348 · edgar.xml · nonDerivative · entry 1 O'Keefe Kylie · CIK 0002118100 · Chief Customer & Strat Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,864 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:45 UTC |
Springhorn Jeremy P.Director
|
SaleOrdinary Shares | 1,993 | $27.06 | $53,930.58 |
DisclosureSEC source: 0000904454-26-000346 · edgar.xml · nonDerivative · entry 2 Springhorn Jeremy P. · CIK 0001717852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,251 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:15 UTC |
Jacques Rachelle SuzanneDirector
|
SaleOrdinary Shares | 1,993 | $27.06 | $53,930.58 |
DisclosureSEC source: 0000904454-26-000339 · edgar.xml · nonDerivative · entry 2 Jacques Rachelle Suzanne · CIK 0001772610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,903 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:38 UTC |
POST LEONARD EDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,980 | $0.00 Strike: $26.82 | $0.00 |
DisclosureSEC source: 0000904454-26-000344 · edgar.xml · derivative · entry 3 POST LEONARD E · CIK 0001235862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980 Underlying: Ordinary Shares · 13,980 shares Expires 2036-06-10 F4 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:38 UTC |
POST LEONARD EDirector
|
GrantOrdinary Shares | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000344 · edgar.xml · nonDerivative · entry 1 POST LEONARD E · CIK 0001235862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,487 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:30 UTC |
Kaye JackDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,980 | $0.00 Strike: $26.82 | $0.00 |
DisclosureSEC source: 0000904454-26-000342 · edgar.xml · derivative · entry 3 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980 Underlying: Ordinary Shares · 13,980 shares Expires 2036-06-10 F4 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:30 UTC |
Kaye JackDirector
|
GrantOrdinary Shares | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000342 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,989 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:13 UTC |
Meek David D.Director
|
GrantStock Option (Right to Buy) · Derivative | 13,980 | $0.00 Strike: $26.82 | $0.00 |
DisclosureSEC source: 0000904454-26-000352 · edgar.xml · derivative · entry 3 Meek David D. · CIK 0001555337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980 Underlying: Ordinary Shares · 13,980 shares Expires 2036-06-10 F4 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:13 UTC |
Meek David D.Director
|
GrantOrdinary Shares | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000352 · edgar.xml · nonDerivative · entry 1 Meek David D. · CIK 0001555337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,740 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:08 UTC |
Balachandran MadhavanDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,980 | $0.00 Strike: $26.82 | $0.00 |
DisclosureSEC source: 0000904454-26-000337 · edgar.xml · derivative · entry 3 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980 Underlying: Ordinary Shares · 13,980 shares Expires 2036-06-10 F4 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:08 UTC |
Balachandran MadhavanDirector
|
GrantOrdinary Shares | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000337 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,247 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:04 UTC |
Gut RobertDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,980 | $0.00 Strike: $26.82 | $0.00 |
DisclosureSEC source: 0000904454-26-000350 · edgar.xml · derivative · entry 8 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,980 Underlying: Ordinary Shares · 13,980 shares Expires 2036-06-10 F9 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:04 UTC |
Gut RobertDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,645 | $0.00 Strike: $16.04 | $0.00 |
DisclosureSEC source: 0000904454-26-000350 · edgar.xml · derivative · entry 7 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,645 shares Expires 2032-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F8 · derivative.exercise_date: The Stock Option vested in full on February 24, 2023. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:04 UTC |
Gut RobertDirector
|
GrantOrdinary Shares | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000350 · edgar.xml · nonDerivative · entry 5 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,985 F5 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:04 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 1,780 | $26.05 | $46,369.00 |
DisclosureSEC source: 0000904454-26-000350 · edgar.xml · nonDerivative · entry 4 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,435 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.14 . The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:04 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 3,127 | $26.03 | $81,395.81 |
DisclosureSEC source: 0000904454-26-000350 · edgar.xml · nonDerivative · entry 3 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,215 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:04 UTC |
Gut RobertDirector
|
SaleOrdinary Shares | 2,645 | $26.07 | $68,955.15 |
DisclosureSEC source: 0000904454-26-000350 · edgar.xml · nonDerivative · entry 2 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,342 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 22:04 UTC |
Gut RobertDirector
|
Exercise / conversionOrdinary Shares | 2,645 | $16.04 | $42,425.80 |
DisclosureSEC source: 0000904454-26-000350 · edgar.xml · nonDerivative · entry 1 Gut Robert · CIK 0001716268 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:45 UTC |
Springhorn Jeremy P.Director
|
GrantStock Option (Right to Buy) · Derivative | 13,980 | $0.00 Strike: $26.82 | $0.00 |
DisclosureSEC source: 0000904454-26-000346 · edgar.xml · derivative · entry 3 Springhorn Jeremy P. · CIK 0001717852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980 Underlying: Ordinary Shares · 13,980 shares Expires 2036-06-10 F4 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:45 UTC |
Springhorn Jeremy P.Director
|
GrantOrdinary Shares | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000346 · edgar.xml · nonDerivative · entry 1 Springhorn Jeremy P. · CIK 0001717852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,244 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:15 UTC |
Jacques Rachelle SuzanneDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,980 | $0.00 Strike: $26.82 | $0.00 |
DisclosureSEC source: 0000904454-26-000339 · edgar.xml · derivative · entry 3 Jacques Rachelle Suzanne · CIK 0001772610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,980 Underlying: Ordinary Shares · 13,980 shares Expires 2036-06-10 F4 · derivative.exercise_date: The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:15 UTC |
Jacques Rachelle SuzanneDirector
|
GrantOrdinary Shares | 7,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000339 · edgar.xml · nonDerivative · entry 1 Jacques Rachelle Suzanne · CIK 0001772610 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,896 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:43 UTC |
Kaye JackDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,645 | $0.00 Strike: $16.04 | $0.00 |
DisclosureSEC source: 0000904454-26-000335 · edgar.xml · derivative · entry 3 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,645 shares Expires 2032-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · derivative.exercise_date: The Stock Option vested in full on February 24, 2023. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:43 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 2,645 | $30.01 | $79,376.45 |
DisclosureSEC source: 0000904454-26-000335 · edgar.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,439 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:43 UTC |
Kaye JackDirector
|
Exercise / conversionOrdinary Shares | 2,645 | $16.04 | $42,425.80 |
DisclosureSEC source: 0000904454-26-000335 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:54 UTC |
Abi-Saab WalidChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $5.59 | $0.00 |
DisclosureSEC source: 0000904454-26-000260 · edgar.xml · derivative · entry 4 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,500 Underlying: Ordinary Shares · 25,000 shares Expires 2034-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option was granted on March 1, 2024 and vested 25% on the first anniversary of the date of grant, and vests 6.25% quarterly thereafter until fully vested. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:54 UTC |
Abi-Saab WalidChief Medical Officer
|
SaleOrdinary Shares | 20,000 | $25.00 | $500,000.00 |
DisclosureSEC source: 0000904454-26-000260 · edgar.xml · nonDerivative · entry 3 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 169,669 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:54 UTC |
Abi-Saab WalidChief Medical Officer
|
SaleOrdinary Shares | 25,000 | $25.10 | $627,500.00 |
DisclosureSEC source: 0000904454-26-000260 · edgar.xml · nonDerivative · entry 2 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,669 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.29. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:54 UTC |
Abi-Saab WalidChief Medical Officer
|
Exercise / conversionOrdinary Shares | 25,000 | $5.59 | $139,750.00 |
DisclosureSEC source: 0000904454-26-000260 · edgar.xml · nonDerivative · entry 1 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:07 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
GrantStock Option (Right to Buy) · Derivative | 113,800 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0000904454-26-000163 · edgar.xml · derivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,800 Underlying: Ordinary Shares · 113,800 shares Expires 2036-03-04 F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:07 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 14,581 | $9.06 | $132,103.86 |
DisclosureSEC source: 0000904454-26-000163 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 660,658 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:07 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
GrantOrdinary Shares | 70,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000163 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 675,239 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:59 UTC |
Abi-Saab WalidChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 67,200 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0000904454-26-000161 · edgar.xml · derivative · entry 3 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,200 Underlying: Ordinary Shares · 67,200 shares Expires 2036-03-04 F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:59 UTC |
Abi-Saab WalidChief Medical Officer
|
SaleOrdinary Shares | 808 | $9.06 | $7,320.48 |
DisclosureSEC source: 0000904454-26-000161 · edgar.xml · nonDerivative · entry 2 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,669 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:59 UTC |
Abi-Saab WalidChief Medical Officer
|
GrantOrdinary Shares | 41,700 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000161 · edgar.xml · nonDerivative · entry 1 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,477 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:35 UTC |
Potts JeannetteChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 57,200 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0000904454-26-000159 · edgar.xml · derivative · entry 3 Potts Jeannette · CIK 0001814693 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,200 Underlying: Ordinary Shares · 57,200 shares Expires 2036-03-04 F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:35 UTC |
Potts JeannetteChief Legal Officer
|
SaleOrdinary Shares | 3,412 | $9.06 | $30,912.72 |
DisclosureSEC source: 0000904454-26-000159 · edgar.xml · nonDerivative · entry 2 Potts Jeannette · CIK 0001814693 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,483 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:35 UTC |
Potts JeannetteChief Legal Officer
|
GrantOrdinary Shares | 35,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000159 · edgar.xml · nonDerivative · entry 1 Potts Jeannette · CIK 0001814693 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,895 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:30 UTC |
KLEMT CHRISTIANChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 63,900 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0000904454-26-000157 · edgar.xml · derivative · entry 3 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,900 Underlying: Ordinary Shares · 63,900 shares Expires 2036-03-04 F4 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:30 UTC |
KLEMT CHRISTIANChief Financial Officer
|
SaleOrdinary Shares | 12,000 | $9.06 | $108,720.00 |
DisclosureSEC source: 0000904454-26-000157 · edgar.xml · nonDerivative · entry 2 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,581 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:30 UTC |
KLEMT CHRISTIANChief Financial Officer
|
GrantOrdinary Shares | 39,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000157 · edgar.xml · nonDerivative · entry 1 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,581 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 10, 2026 01:00 UTC |
O'Keefe KylieChief Customer & Strat Officer
|
GrantStock Option (Right to Buy) · Derivative | 31,900 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0000904454-26-000170 · edgar.xml · derivative · entry 2 O'Keefe Kylie · CIK 0002118100 · Chief Customer & Strat Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,900 Underlying: Ordinary Shares · 31,900 shares Expires 2036-03-04 F2 · derivative.exercise_date: The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 04, 2026 Filed Mar 10, 2026 01:00 UTC |
O'Keefe KylieChief Customer & Strat Officer
|
GrantOrdinary Shares | 19,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000170 · edgar.xml · nonDerivative · entry 1 O'Keefe Kylie · CIK 0002118100 · Chief Customer & Strat Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,800 F1 · shares: Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:42 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 34,437 | $9.95 | $342,648.15 |
DisclosureSEC source: 0000904454-26-000154 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604,639 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.67 to $10.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:36 UTC |
KLEMT CHRISTIANChief Financial Officer
|
SaleOrdinary Shares | 12,532 | $9.95 | $124,693.40 |
DisclosureSEC source: 0000904454-26-000152 · edgar.xml · nonDerivative · entry 1 KLEMT CHRISTIAN · CIK 0001711885 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,981 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.67 to $10.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:31 UTC |
Potts JeannetteChief Legal Officer
|
SaleOrdinary Shares | 8,578 | $9.95 | $85,351.10 |
DisclosureSEC source: 0000904454-26-000150 · edgar.xml · nonDerivative · entry 1 Potts Jeannette · CIK 0001814693 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,495 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.67 to $10.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:25 UTC |
Abi-Saab WalidChief Medical Officer
|
SaleOrdinary Shares | 1,660 | $9.95 | $16,517.00 |
DisclosureSEC source: 0000904454-26-000148 · edgar.xml · nonDerivative · entry 1 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,777 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.67 to $10.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.